Number of Shares
1.06 Mil
Current Holdings Value*
$38.21 Mil
% of Portfolio
2.87%
Total Estimate Gain
$-10.14 Mil
% of Total Estimate Gain
-26.78%

Cormorant Asset Management, LP's Bright Minds Biosciences Inc Holding Summary

As of 2025-03-31, Cormorant Asset Management, LP held 1.06 Mil shares of Bright Minds Biosciences Inc(DRUG), totaling $38.21 Mil. This investment constitutes 2.87% of their stock portfolio, and Cormorant Asset Management, LP now holds 15.05% of the outstanding Bright Minds Biosciences Inc(DRUG) stock.

The initial trade took place in 2024Q4. And since then Cormorant Asset Management, LP has made 1 purchases of DRUG, at an average price of $35.73, for a total of 1.06 Mil shares. Based on historical transaction data and DRUG's current price of $26.16, Cormorant Asset Management, LP's estimated gain on his DRUG holdings is $-10.14 Mil, reflecting a -26.78% gain to date.

Cormorant Asset Management, LP DRUG ($26.16) Holding Chart

Cormorant Asset Management, LP DRUG ($26.16) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1